Abbott Laboratories
ABT
$132.58
$3.222.49%
NYSE
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 7.57% | -5.61% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.57% | -5.61% | |||
| Cost of Revenue | 8.96% | -10.36% | |||
| Gross Profit | 6.52% | -1.68% | |||
| SG&A Expenses | 1.34% | 5.90% | |||
| Depreciation & Amortization | 0.00% | -9.68% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.42% | -5.04% | |||
| Operating Income | 17.29% | -8.14% | |||
| Income Before Tax | 20.92% | -12.41% | |||
| Income Tax Expenses | -18.10% | 106.29% | |||
| Earnings from Continuing Operations | 34.26% | -85.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 34.26% | -85.64% | |||
| EBIT | 17.29% | -8.14% | |||
| EBITDA | 13.12% | -7.62% | |||
| EPS Basic | 33.95% | -85.53% | |||
| Normalized Basic EPS | 18.35% | -3.90% | |||
| EPS Diluted | 32.89% | -85.56% | |||
| Normalized Diluted EPS | 18.40% | -4.34% | |||
| Average Basic Shares Outstanding | 0.24% | -0.39% | |||
| Average Diluted Shares Outstanding | 0.21% | 0.07% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.25% | 6.46% | |||